IR

2.2K posts

IR banner
IR

IR

@itrisabel

Breast surgical oncologist, Head, Breast Unit, Working for better training and equity in surgical oncology. #breastcancer. wordl traveler #ILookLikeASurgeon

Madrid, Spain Katılım Mart 2014
310 Takip Edilen870 Takipçiler
IR retweetledi
Dra. María Natalia Gandur Quiroga
⭐ HER2+ early breast cancer: de-escalation with precision ⭐ An important @OncoAlert exclusive for #ASCO26 with Dr. @JavierCortesMD discussing PHERGain and PHERGain-2. 🚨🎗️ These studies speak to one of the most relevant questions in early HER2+ breast cancer: Can we safely personalize treatment intensity and reduce chemotherapy exposure in selected patients? A chemotherapy-free, pCR-guided strategy with dual HER2 blockade is not just about response. It is about smarter treatment selection, less toxicity, preserving quality of life, and moving de-escalation from concept to carefully tested clinical strategy. 🧬🩺 Looking forward to this discussion with the OncoAlert Breast faculty. 🌍🤝 @ElisaAgostinett @to_be_elizabeth @WeOncologists @ErikaHamilton9 @E_de_Azambuja @matteolambe @DrSGraff @hoperugo @BianchiniGP @Icro_Meattini @Lucarecco @GaiaGriguolo @aftimosp @double_whammied @stage4kelly @coffeemommy @itsnot_pink @maryam_lustberg @IBCResearch @kevinpunie @nicolobattisti @raalbany @teamoncology @stolaney1 @LoiSher @SirohiBhawna @chemobrainfog @jamecancerdoc @JaniceTNBCmets @Prof_Nadia_H @paspears88 @MammaMiaMagazin @itrisabel @wearemedsir #OncoAlert #ASCO26 #BreastCancer #HER2Positive #CancerCare
OncoAlert@OncoAlert

An OncoAlert Exclusive at #ASCO26 Our OncoAlert #BreastCancer Faculty Dr. Javier Cortes presents the recent results of the PHERGain and PHERGain2 studies presented in Berlin for ESMO Breast. PHERGain-2 demonstrates that a chemotherapy-free, pCR-guided strategy can achieve high response rates in selected patients with early HER2-positive breast cancer. Dual HER2 blockade produced pCR rates near 60%, enabling treatment personalization, reducing chemotherapy exposure, preserving quality of life, and supporting further de-escalation of therapy in carefully selected patients. Leads🚨 @ElisaAgostinett @to_be_elizabeth @WeOncologists Senior Faculty @ErikaHamilton9 @E_de_Azambuja @matteolambe @DrSGraff @hoperugo @BianchiniGP Dr. Bidard @Icro_Meattini Participating AF @Lucarecco @GaiaGriguolo Ping Faculty @aftimosp @double_whammied @stage4kelly @coffeemommy @itsnot_pink @maryam_lustberg @IBCResearch @kevinpunie @nicolobattisti @raalbany @teamoncology @stolaney1 @LoiSher @SirohiBhawna @chemobrainfog @jamecancerdoc @JavierCortesMD @JaniceTNBCmets @Prof_Nadia_H @paspears88 @MammaMiaMagazin @itrisabel @wearemedsir

English
0
3
11
1.2K
IR retweetledi
OncoAlert
OncoAlert@OncoAlert·
As we get started with #ASCO26, what better way to brush up with what has happened the last year in #BreastCancer Presentation 👉 buff.ly/l3G1CGn Get a 13 minute breakdown on ER+ Metastatic Breast Cancer from OncoAlert Faculty Dr. Erika Hamilton of Sarah Cannon🇺🇸 #BreastCancer @hoperugo 🇺🇸 @matteolambe 🇮🇹 @Icro_Meattini 🇮🇹 Dr. Roberto Salgado 🇧🇪 @ErikaHamilton9 🇺🇸 @DrSGraff 🇺🇸 @itrisabel 🇪🇸 @ESSOnews @ElisaAgostinett 🇧🇪 @RebeccaDSing 🇸🇬 @LazarPo31787807 🇷🇸 @aftimosp @to_be_elizabeth @GaiaGriguolo @Lucarecco Our Partners @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg
English
0
6
12
666
IR retweetledi
OncoAlert
OncoAlert@OncoAlert·
OncoAlert 🚨 Coverage of DAY ONE of #EBCC15 Breast Cancer and Communication: Patient Insights from Serbia Presented by Sara Bojanic An online survey conducted by Europa Donna Serbia in late 2024 among 810 women diagnosed with breast cancer reveals significant gaps in communication between patients and healthcare professionals in Serbia. Despite respondents being largely well educated, more than half reported receiving only partial information, limited time for discussion, and an incomplete understanding of their diagnosis and treatment options, often prompting them to seek information elsewhere. While the information provided was generally perceived as helpful, many patients felt insufficiently informed and unable to ask questions. The findings highlight an urgent need for clearer, more patient‑centred communication, improved health communication skills among professionals, and stronger patient involvement across the breast cancer care pathway. #BreastCancer @itrisabel @JavierCortesMD @MIgnatiadis @MichaelGnant @Icro_Meattini @matteolambe @c_sotiriou @aftimosp @MOliveira_MD @CarmenCriscit @lab_kok @to_be_elizabeth @ElisaAgostinett @Lucarecco @FernandoOnco @GaiaGriguolo @JankovicK @acampsmalea @kevinpunie @CarmineDeA1 @LauBuisseret
OncoAlert tweet media
English
0
11
11
920
IR retweetledi
OncoAlert
OncoAlert@OncoAlert·
OncoAlert 🚨 Coverage of DAY ONE of #EBCC15 RAPCHEM Study Presented by Dr Fleur Mauritz A ten-year study shows that tailoring radiotherapy after chemotherapy and surgery to a patient’s individual risk keeps breast cancer recurrence rates very low while potentially reducing side-effects. In 848 patients treated in the Netherlands, radiotherapy was adjusted based on whether cancer remained in the lymph nodes after treatment, allowing some low‑risk patients to receive minimal or no radiotherapy. After a decade of follow‑up, only 2.9% experienced a local or regional recurrence, with similarly low rates across low-, intermediate- and high‑risk groups. The findings suggest that carefully stratifying patients by response to chemotherapy can safely reduce overtreatment and support more personalised breast cancer care. For the final conclusion, we will have to wait for the results of a randomised trial from the USA, which are expected in three years. #BreastCancer @itrisabel @JavierCortesMD @MIgnatiadis @MichaelGnant @Icro_Meattini @matteolambe @c_sotiriou @aftimosp @MOliveira_MD @CarmenCriscit @lab_kok @to_be_elizabeth @ElisaAgostinett @Lucarecco @FernandoOnco @GaiaGriguolo @JankovicK @acampsmalea @kevinpunie @CarmineDeA1 @LauBuisseret
OncoAlert tweet mediaOncoAlert tweet mediaOncoAlert tweet mediaOncoAlert tweet media
English
2
12
12
1.2K
IR retweetledi
Icro Meattini
Icro Meattini@Icro_Meattini·
Etienne Brain awarded at #EBCC15 👏 A well-deserved recognition followed by an insightful lecture on one of the most pressing issues in our field: treatment challenges and decision-making in elderly patients with #BreastCancer @EtienneB66 @OncoAlert #OncoAlert
Icro Meattini tweet mediaIcro Meattini tweet mediaIcro Meattini tweet mediaIcro Meattini tweet media
English
0
6
15
1.1K
IR retweetledi
Judy Boughey
Judy Boughey@DrJudyBoughey·
Launch of the SSO Career Catalyst Mentorship Program 2026-2027 cohort. Excited to be a mentor in this program @SocSurgOnc
Judy Boughey tweet mediaJudy Boughey tweet media
English
1
4
16
1.4K
IR
IR@itrisabel·
Celebrating World Cancer day!! Evidence based prevention strategies and treatments drives progress to reduce the burden of cancer!!
IR tweet media
English
0
1
12
691
IR retweetledi
European Society of Surgical Oncology (ESSO)
We are happy to join again the 2026 OncoAlert Colloquium! With ESSO reps presenting highlights in: ➡️ @itrisabel on #BreastCancer surgery ➡️ Johnn Henry Herrera Kok on lower #GIsurgery ➡️ Marco Inama on upper #GIsurgery
OncoAlert@OncoAlert

Dear Colleagues Coming February 2026: The 6th Annual OncoAlert Colloquium 🚨 REGISTER👉 oncoalert.m-pages.com/7I0mwF/the-202… Our Faculty List Keeps on Growing and As ALWAYS ✅Patients Included #BreastCancer @hoperugo🇺🇸 @matteolambe🇮🇹 @Icro_Meattini🇮🇹 Dr. Roberto Salgado 🇧🇪 @ErikaHamilton9 🇺🇸 @DrSGraff 🇺🇸 @itrisabel🇪🇸 @ESSOnews @ElisaAgostinett 🇧🇪 Dr. Fatima Cardoso 🇵🇹 @LazarPo31787807 🇷🇸 #LungCancer @GlopesMd🇺🇸 @jillfeldman4 @EGFRResisters🇺🇸 @UmbertoMalapel1 🇮🇹 @isliquidbiopsy @BRicciutiMD 🇺🇸 @gerryhanna 🇮🇪 @UOzkerim 🇹🇷 GU Oncology @brian_rini 🇺🇸 @declangmurphy 🇦🇺 @KidneyCancer🇺🇸 @salvolarosa @APCCC_Lugano🇨🇭 @RenuEapen🇦🇺 @nataliagandur 🇦🇷 @seanmcbride 🇺🇸 @GuardConsortium 🇪🇸 GI Oncology @BenWestphalen 🇩🇪 @florianlordick 🇩🇪 @NiuSanford 🇺🇸 @realbowtiedoc 🇺🇸 @ARosen380 🇺🇸 @Erman_Akkus 🇹🇷 John Herrera Kok Melanoma @DrBetofMDPhD 🇺🇸 Myeloma @Abdallah81MD 🇺🇸 Our Partners @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg Our Collaborators APCCC, GU CAST, Uromigos and more and more to come....... #OncoAlertAF @FernandoOnco @to_be_elizabeth @bavilima @GaiaGriguolo @JankovicK @MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @DrRishabhOnco @Onco_Cifu88 @PaulJiL

English
0
4
9
1.3K
IR retweetledi
OncoAlert
OncoAlert@OncoAlert·
Dear Colleagues Coming February 2026: The 6th Annual OncoAlert Colloquium 🚨 REGISTER👉 oncoalert.m-pages.com/7I0mwF/the-202… Our Faculty List Keeps on Growing and As ALWAYS ✅Patients Included #BreastCancer @hoperugo🇺🇸 @matteolambe🇮🇹 @Icro_Meattini🇮🇹 Dr. Roberto Salgado 🇧🇪 @ErikaHamilton9 🇺🇸 @DrSGraff 🇺🇸 @itrisabel🇪🇸 @ESSOnews @ElisaAgostinett 🇧🇪 Dr. Fatima Cardoso 🇵🇹 @LazarPo31787807 🇷🇸 #LungCancer @GlopesMd🇺🇸 @jillfeldman4 @EGFRResisters🇺🇸 @UmbertoMalapel1 🇮🇹 @isliquidbiopsy @BRicciutiMD 🇺🇸 @gerryhanna 🇮🇪 @UOzkerim 🇹🇷 GU Oncology @brian_rini 🇺🇸 @declangmurphy 🇦🇺 @KidneyCancer🇺🇸 @salvolarosa @APCCC_Lugano🇨🇭 @RenuEapen🇦🇺 @nataliagandur 🇦🇷 @seanmcbride 🇺🇸 @GuardConsortium 🇪🇸 GI Oncology @BenWestphalen 🇩🇪 @florianlordick 🇩🇪 @NiuSanford 🇺🇸 @realbowtiedoc 🇺🇸 @ARosen380 🇺🇸 @Erman_Akkus 🇹🇷 John Herrera Kok Melanoma @DrBetofMDPhD 🇺🇸 Myeloma @Abdallah81MD 🇺🇸 Our Partners @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg Our Collaborators APCCC, GU CAST, Uromigos and more and more to come....... #OncoAlertAF @FernandoOnco @to_be_elizabeth @bavilima @GaiaGriguolo @JankovicK @MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @DrRishabhOnco @Onco_Cifu88 @PaulJiL
English
2
22
37
8.8K
IR retweetledi
OncoAlert
OncoAlert@OncoAlert·
Dear Colleagues Coming 1⃣st Week of February 2026: The 6th Annual OncoAlert Colloquium 🚨 REGISTER👉 buff.ly/UDfpkP8 Our Faculty List Keeps on Growing and As ALWAYS ✅Patients Included #BreastCancer @hoperugo🇺🇸 @matteolambe🇮🇹 @Icro_Meattini🇮🇹 Dr. Roberto Salgado 🇧🇪 @ErikaHamilton9 🇺🇸 @DrSGraff 🇺🇸 @E_de_Azambuja 🇧🇪 @itrisabel🇪🇸 ESSO @ElisaAgostinett 🇧🇪 Dr. Fatima Cardoso 🇵🇹 @ABCGlobalAll @LazarPo31787807 🇷🇸 #LungCancer @GlopesMd🇺🇸 @jillfeldman4 @EGFRResisters🇺🇸 @UmbertoMalapel1 🇮🇹 @isliquidbiopsy @BRicciutiMD 🇺🇸 @UOzkerim 🇹🇷 GU Oncology @brian_rini @Uromigos🇺🇸 @declangmurphy @gu_onc🇦🇺 @KidneyCancer🇺🇸 @APCCC_Lugano🇨🇭 @RenuEapen🇦🇺 @nataliagandur 🇦🇷 @seanmcbride 🇺🇸 GI Oncology @BenWestphalen 🇩🇪 @CathyEngMD 🇺🇸 @florianlordick 🇩🇪 @NiuSanford 🇺🇸 @realbowtiedoc 🇺🇸 @ARosen380 🇺🇸 @Erman_Akkus 🇹🇷 Melanoma @DrBetofMDPhD 🇺🇸 Our Partners @ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg Our Collaborators APCCC, GU CAST, @Uromigos and more and more to come....... #OncoAlertAF @HHorinouchi @FernandoOnco @ElisaAgostinett @to_be_elizabeth @GaiaGriguolo @MarioBalsaMD @DrMirallas @GIMedOnc @DrRishabhOnco @Onco_Cifu88 @PaulJiL
English
0
21
33
9.9K
IR retweetledi
IR retweetledi